Generating translatable high-content imaging data from physiologically-relevant cell models, including 2D and 3D structures, is extremely valuable for drug discovery and pre-clinical research. In this webinar, Dr. Raymond Price of PhenoVista Biosciences presents case studies on how Yokogawa’s Benchtop CQ1 Confocal System can improve throughput and standardize processes for complex 3D cell-based phenotypic assays.
Key learning objectives:
- Strategies for designing and implementing high-content screening assays
- Approaches for deciding between 2D and 3D model systems
Related Industries
-
Pharmaceutical
Under continual pressure to increase profitability, maintain government compliance, and meet emerging market opportunities, the pharmaceutical manufacturing industry faces unique challenges that require unique solutions. As one of the world’s leading industrial automation suppliers, Yokogawa is poised and prepared to deliver those solutions, creating individualized lean manufacturing techniques that deliver consistent, measurable results.
Related Products & Solutions
-
Benchtop CQ1 Confocal System
Optimize lab space while driving fast, accurate results.
-
CellPathfinder
Cell imaging software supports label-free samples and provides multiple graphing options with a streamlined, easy-to-use interface.
-
CV8000 High-Throughput System
Simplify and accelerate workflow processes with the CV8000.
-
High-Content Analysis Systems
Utilizing powerful software, high-content analysis (HCA) systems address a wide range of research applications from basic science to complex compound screening.